JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: The small JAK2 V617F mutation clone was identified by cdPCR from the primary CML to CML-CR stage, with the mutant allele burden increasing from 0.27% to 5.85% (Fig. 3B).